229 related articles for article (PubMed ID: 29549708)
1. Detection and Identification of Serum Peptides Biomarker in Papillary Thyroid Cancer.
Lu ZL; Chen YJ; Jing XY; Wang NN; Zhang T; Hu CJ
Med Sci Monit; 2018 Mar; 24():1581-1587. PubMed ID: 29549708
[TBL] [Abstract][Full Text] [Related]
2. Application Value of Mass Spectrometry in the Differentiation of Benign and Malignant Liver Tumors.
Li B; Li B; Guo T; Sun Z; Li X; Li X; Wang H; Chen W; Chen P; Qiao M; Xia L; Mao Y
Med Sci Monit; 2017 Apr; 23():1636-1644. PubMed ID: 28376075
[TBL] [Abstract][Full Text] [Related]
3. Discovery and identification of potential biomarkers of papillary thyroid carcinoma.
Fan Y; Shi L; Liu Q; Dong R; Zhang Q; Yang S; Fan Y; Yang H; Wu P; Yu J; Zheng S; Yang F; Wang J
Mol Cancer; 2009 Sep; 8():79. PubMed ID: 19785722
[TBL] [Abstract][Full Text] [Related]
4. Serum peptide profiling for potential biomarkers in early diagnosis of Escherichia coli bloodstream infection.
Ma Y; Chen C; Yang M; He S; Zhang K; Wang C
Cytokine; 2019 Aug; 120():71-77. PubMed ID: 31026733
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
6. [Detection and identification of specific serum biomarkers in papillary thyroid cancer].
Wang JX; Dong R; Liu QL; Yang SB; Fan YX; Zhang Q; Yang FQ; Wu P; Yu JK; Zheng S
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):265-8. PubMed ID: 19615280
[TBL] [Abstract][Full Text] [Related]
7. The differential diagnostic model for serous peptidomics in HBV carriers established by MALDI-TOF-MS analysis.
Tian L; Wang Y; Xu D; Gao Y; Wen X; Tian Y
Clin Biochem; 2014 Jan; 47(1-2):56-62. PubMed ID: 24183880
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the raw serum peptidomic pattern in glioma patients.
Li Z; Lu H; Yang J; Zeng X; Zhao L; Li H; Liao Q; Peng S; Zhou M; Wu M; Xiang J; Wang Y; Li G
Clin Chim Acta; 2013 Oct; 425():221-6. PubMed ID: 23954773
[TBL] [Abstract][Full Text] [Related]
9. Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age.
Villanueva J; Martorella AJ; Lawlor K; Philip J; Fleisher M; Robbins RJ; Tempst P
Mol Cell Proteomics; 2006 Oct; 5(10):1840-52. PubMed ID: 16896061
[TBL] [Abstract][Full Text] [Related]
10. MALDI-TOF-MS analysis in low molecular weight serum peptidome biomarkers for NSCLC.
Song Y; Xu X; Wang N; Zhang T; Hu C
J Clin Lab Anal; 2022 Apr; 36(4):e24254. PubMed ID: 35212031
[TBL] [Abstract][Full Text] [Related]
11. Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer.
Wu C; Luo Z; Tang D; Liu L; Yao D; Zhu L; Wang Z
Tumour Biol; 2016 May; 37(5):6963-70. PubMed ID: 26662807
[TBL] [Abstract][Full Text] [Related]
12. Detection of papillary thyroid carcinoma with serum protein profile analysis.
Moretz WH; Gourin CG; Terris DJ; Xia ZS; Liu Z; Weinberger PM; Chin E; Adam BL
Arch Otolaryngol Head Neck Surg; 2008 Feb; 134(2):198-202. PubMed ID: 18283164
[TBL] [Abstract][Full Text] [Related]
13. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
[TBL] [Abstract][Full Text] [Related]
14. Identification of serum biomarkers for occupational medicamentosa-like dermatitis induced by trichloroethylene using mass spectrometry.
Hong WX; Liu W; Zhang Y; Huang P; Yang X; Ren X; Ye J; Huang H; Tang H; Zhou G; Huang X; Zhuang Z; Liu J
Toxicol Appl Pharmacol; 2013 Nov; 273(1):121-9. PubMed ID: 23994554
[TBL] [Abstract][Full Text] [Related]
15. Serum peptidome profiling for the diagnosis of colorectal cancer: discovery and validation in two independent cohorts.
Wang H; Luo C; Zhu S; Fang H; Gao Q; Ge S; Qu H; Ma Q; Ren H; Wang Y; Wang W
Oncotarget; 2017 Aug; 8(35):59376-59386. PubMed ID: 28938643
[TBL] [Abstract][Full Text] [Related]
16. Imaging mass spectrometry in papillary thyroid carcinoma for the identification and validation of biomarker proteins.
Min KW; Bang JY; Kim KP; Kim WS; Lee SH; Shanta SR; Lee JH; Hong JH; Lim SD; Yoo YB; Na CH
J Korean Med Sci; 2014 Jul; 29(7):934-40. PubMed ID: 25045225
[TBL] [Abstract][Full Text] [Related]
17. RNA-Binding Motif Protein 6 is a Candidate Serum Biomarker for Pancreatic Cancer.
Duan B; Hu X; Fan M; Xiong X; Han L; Wang Z; Tong D; Liu L; Wang X; Li W; Yang J; Huang C
Proteomics Clin Appl; 2019 Sep; 13(5):e1900048. PubMed ID: 31207145
[TBL] [Abstract][Full Text] [Related]
18. Plasma Peptidome Pattern of Breast Cancer Using Magnetic Beads-Based Plasma Fractionation and MALDI-TOF MS: A Case Control Study in Egypt.
Zaki A; Ramadan RA; Moez P; Ghareeb H; Elkarmouty A
Asian Pac J Cancer Prev; 2019 Jan; 20(1):175-184. PubMed ID: 30678429
[TBL] [Abstract][Full Text] [Related]
19. S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging.
Nipp M; Elsner M; Balluff B; Meding S; Sarioglu H; Ueffing M; Rauser S; Unger K; Höfler H; Walch A; Zitzelsberger H
J Mol Med (Berl); 2012 Feb; 90(2):163-74. PubMed ID: 21938494
[TBL] [Abstract][Full Text] [Related]
20. The discovery and identification of a candidate proteomic biomarker of active tuberculosis.
Liu J; Jiang T; Wei L; Yang X; Wang C; Zhang X; Xu D; Chen Z; Yang F; Li JC
BMC Infect Dis; 2013 Oct; 13():506. PubMed ID: 24168695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
